25Feb/18

Cyclophosphamide combination superior for graft-versus-host disease prophylaxis – Healio

Cyclophosphamide combination superior for graft-versus-host disease prophylaxis
Healio
All patients received peripheral blood stem cell grafts from 6/6 HLA-matched related or 7-8/8 HLA-matched unrelated donors. GVHD-free and relapse-free survival — defined as time from transplantation to onset of grade 3 or grade 4 acute GVHD, chronic